Borregaard ASA (LON:0QB7)
London · Delayed Price · Currency is GBP · Price in NOK | Market Cap | 1.12B -16.8% |
| Revenue (ttm) | 597.34M +0.1% |
| Net Income | 42.84M -37.0% |
| EPS | 0.43 -37.0% |
| Shares Out | n/a |
| PE Ratio | 26.02 |
| Forward PE | 15.86 |
| Dividend | 0.37 (0.26%) |
| Ex-Dividend Date | Apr 17, 2026 |
| Volume | 9,589 |
| Open | 141.10 |
| Previous Close | 141.45 |
| Day's Range | 138.80 - 140.00 |
| 52-Week Range | 138.80 - 211.50 |
| Beta | 0.59 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jul 16, 2026 |
About Borregaard ASA
Borregaard ASA engages in the development, production, and marketing of specialized biochemicals and biomaterials in Norway, rest of Europe, Asia, the United States, and internationally. It operates in three segments: BioSolutions, BioMaterials, and Fine Chemicals. The BioSolutions segment develops, produces, and sells biopolymers and biovanillin derived from lignin for agrochemicals, batteries, industrial binders, and construction, as well as to flavor and fragrance companies, and food and beverage industry. Its BioMaterials segment develops, ... [Read more]
Financial Performance
In 2025, Borregaard ASA's revenue was 7.71 billion, an increase of 1.26% compared to the previous year's 7.62 billion. Earnings were 620.00 million, a decrease of -24.67%.
Financial numbers in NOK Financial StatementsNews
Borregaard ASA: Alginor faces a challenging financial situation
In recent months, Alginor has seen challenges with raw material supply, delayed product development and commercialisation, and additional cost overruns in the demonstration plant investment. As of now...
Borregaard ASA: Initiation of share repurchase programme
8 May 2026: Borregaard ASA ("Borregaard", OSE ticker: BRG) Borregaard intends to repurchase up to 300,000 shares of its outstanding common stock. The shares will be used for employee incentive program...
Borregaard ASA Earnings Call Transcript: Q1 2026
EBITDA and revenues declined year-over-year due to lower BioSolutions volumes and higher costs, while Fine Chemicals posted strong growth. Geopolitical uncertainty and cost inflation are impacting outlook, but targeted cost measures and a diversified portfolio provide resilience.
Borregaard ASA Quarterly report: Q1 2026
Borregaard ASA has published its Q1 2026 quarterly earnings report on April 29, 2026.
Borregaard ASA Slides: Q1 2026
Borregaard ASA has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 29, 2026.
Borregaard ASA: EBITDA1 of NOK 428 million in the 1st quarter
Borregaard's operating revenues were NOK 2,005 million (NOK 2,036 million) in the 1st quarter of 2026. EBITDA1 was NOK 428 million (NOK 511 million). The result in Fine Chemicals increased, while BioS...
Borregaard ASA Slides: Company presentation
Borregaard ASA has posted slides in relation to its latest quarterly earnings report, which was published on April 29, 2026.
Borregaard ASA: Shares traded ex-dividend today
The shares in Borregaard ASA will be traded ex-dividend of NOK 4.75 per share as from today, 17 April 2026. Borregaard ASASarpsborg, 17 April 2026 Contact: Lotte Kvinlaug, Investor Relations Officer, ...
Borregaard ASA Transcript: AGM 2026
The AGM approved all proposals, including a 12% higher dividend, board and committee elections, and remuneration adjustments. Financial results showed strong growth, with strategic investments in specialization, sustainability, and capacity expansion. No shareholder objections or questions were raised.
Borregaard ASA Transcript: Pre-close call
Sales volumes are set to rise in both BioSolutions and BioMaterials for 2026, though average prices in BioMaterials will decline due to mix and market pressures. Cost volatility, global conflicts, and competition from Chinese imports remain key risks, while currency impacts and hedging strategies are closely monitored.
Borregaard ASA Earnings Call Transcript: Q4 2025
All-time high EBITDA was achieved despite lower bioethanol prices and higher costs, with strong cash flow and improved results in BioSolutions and BioMaterials. The dividend is proposed to increase by 12%, and impairments on bio-based startups and a project delay were recorded.
Borregaard ASA Annual report: Q4 2025
Borregaard ASA has published its Q4 2025 annual report on February 4, 2026.
Borregaard ASA Quarterly report: Q4 2025
Borregaard ASA has published its Q4 2025 quarterly earnings report on February 4, 2026.
Borregaard ASA Slides: Q4 2025
Borregaard ASA has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on February 4, 2026.
Borregaard ASA: Key information related to the cash dividend
4 February 2026: Borregaard ASA («Borregaard», OSE ticker: BRG) At a meeting on 3 February 2026, the Board of Directors of Borregaard ASA decided to propose to the Annual General Meeting an ordinary d...
Borregaard ASA: The Board of Directors' dividend proposal to Borregaard's Annual General Meeting
4 February 2026: Borregaard ASA (“Borregaard”, OSE ticker: BRG) At a meeting on 3 February 2026 the Board of Directors of Borregaard ASA decided to propose an ordinary dividend for 2025 of NOK 4.75 pe...
Borregaard ASA: EBITDA1 of NOK 405 million in the 4th quarter 2025
Borregaard's operating revenues increased to NOK 1,833 million (NOK 1,744 million)2 in the 4th quarter of 2025. EBITDA1 was NOK 405 million (NOK 398 million). The result in BioMaterials increased, whi...
Borregaard ASA Slides: Company presentation
Borregaard ASA has posted slides in relation to its latest quarterly earnings report, which was published on February 4, 2026.
Borregaard ASA Slides: SEB Nordic Seminar presentation
Borregaard ASA has posted slides in relation to its latest quarterly earnings report, which was published on January 8, 2026.
Borregaard ASA 4th Quarter 2025 Pre-Close Call Transcript
Borregaard ASA 4th Quarter 2025 Pre-Close Call Transcript
Borregaard ASA Transcript: Pre-Close Call
Q4 outlook reiterates previous guidance, with BioSolutions and BioMaterials volumes slightly down but margins strong. Wood and energy costs are trending favorably, while anti-dumping legal costs and global uncertainties remain key risks.
Borregaard ASA Earnings Call Transcript: Q3 2025
Q3 2025 EBITDA fell to NOK 440 million, mainly due to lower bioethanol prices and a cellulose production disruption. Biosolutions saw continued agricultural growth, while biomaterials and fine chemicals underperformed. Board approved further Sarpsborg expansion and participated in Alginor financing.
Borregaard ASA Quarterly report: Q3 2025
Borregaard ASA has published its Q3 2025 quarterly earnings report on October 22, 2025.
Borregaard ASA Slides: Q3 2025
Borregaard ASA has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on October 22, 2025.
Borregaard ASA Slides: Company Presentation
Borregaard ASA has posted slides in relation to its latest quarterly earnings report, which was published on October 22, 2025.